Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
Public ClinicalTrials.gov record NCT02551731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Study identification
- NCT ID
- NCT02551731
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- INSYS Therapeutics Inc
- Industry
- Enrollment
- 9 participants
Conditions and interventions
Conditions
Interventions
- Cannabidiol Oral Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Months to 36 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2016
- Primary completion
- Sep 5, 2016
- Completion
- Sep 5, 2016
- Last update posted
- Sep 18, 2018
2016
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mattel Children's Hospital at UCLA | Los Angeles | California | 90095 | — |
| University of California - San Francisco | San Francisco | California | 94143 | — |
| Miami Children's Hospital | Miami | Florida | 33155 | — |
| Beaumont Health System | Royal Oak | Michigan | 48073 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02551731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02551731 live on ClinicalTrials.gov.